Search for content and authors
 

ANALYSIS OF GLUTATHIONE AND GLUTATHIONE DISULFIDE STATUS IN SENSITIVE AND RESISTANT HUMAN MELANOMA CELLS TREATED WITH DOXORUBICIN

Jadwiga Marczewska 1Dorota Jakoniuk Elżbieta Anuszewska 

1. National Institute of Public Health, Chełmska 30/34, Warszawa 00-725, Poland

Abstract

The development of resistance to multiple drugs used on cancer chemotherapy is a serious limitation of this form of treatment. In resistant cells there is correlation between decrease drug accumulation and expression of a 170kD cell surface glycoprotein which is designate P-glycoprotein, encoded by the MDR1 gene and 190KD glycoprotein - multidrug resistance protein - MRP1.

There is evidence that the MRP1 gene encodes a human GS-X pump. MRP1 contains multiple transmembrane domains plus two intracellulary localized ATP - binding cassettes, suggesting that it functions as an efflux pump for drug elimination, including doxorubicin.

Cancer cell resistance to antitumor agents has often been found associated with increases in intracellular glutathione (GSH) level.

In the present study we investigated the effect of doxorubicin on GSH level in human melanoma cells, sensitive and resistant. The GSH content was measured by BIOXYTECH® GSH/GSSG - 412TM Kit.

The preliminary study indicate that GSH content in both kinds of cells is many times greater than GSSG content, also human melanoma cells resistant to doxorubicin contain 3 x more GSH than sensitive ones, after 72 h incubation.
 

Legal notice
  • Legal notice:
 

Related papers

Presentation: Poster at V Multidyscyplinarna Konferencja Nauki o Leku, by Jadwiga Marczewska
See On-line Journal of V Multidyscyplinarna Konferencja Nauki o Leku

Submitted: 2006-02-01 19:42
Revised:   2009-06-07 00:44